During Q3, TransEnterix, Inc. Common Stock's (AMEX:TRXC) reported sales totaled $814.00 thousand. Despite a 5.54% in earnings, the company posted a loss of $15.16 million. In Q2, TransEnterix, Inc. Common Stock brought in $655.00 thousand in sales but lost $14.37 million in earnings.
Changes in earnings and sales indicate shifts in TransEnterix, Inc. Common Stock's Return on Capital Employed, a measure of yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth of a company and is a sign of higher earnings per share in the future. In Q3, TransEnterix, Inc. Common Stock posted an ROCE of -0.24%.
It is important to keep in mind ROCE evaluates past performance and is not used as a predictive tool. It is a good measure of a company's recent performance, but several factors could affect earnings and sales in the near future.
ROCE is an important metric for the comparison of similar companies. A relatively high ROCE shows TransEnterix, Inc. Common Stock is potentially operating at a higher level of efficiency than other companies in its industry. If the company is generating high profits with its current level of capital, some of that money can be reinvested in more capital which will generally lead to higher returns and earnings per share growth.
In TransEnterix, Inc. Common Stock's case, the ROCE ratio shows the amount of assets may not be helping the company achieve higher returns. Investors may take this into account before making any long-term financial decisions.
TransEnterix, Inc. Common Stock reported Q3 earnings per share at $-0.12/share, which beat analyst predictions of $-0.23/share.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。